Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mindray Medical International Ltd Announces Management Change


Wednesday, 12 Jun 2013 07:00am EDT 

Mindray Medical International Limited announced that the company has appointed Mr. Cheng Minghe to be co-Chief Executive Officer (co-CEO). Mr. Cheng is the Company's Chief Strategic Officer and will maintain this role. Mr. Li Xiting, Mindray's President and CEO, will now be President and co-CEO and will remain the Company's director of the board. 

Company Quote

26.91
-0.1 -0.37%
19 Dec 2014